Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
ID

IDXX

Market Closed

IDEXX Laboratories, Inc.

NASDAQHealthcareMedical - Diagnostics & Research
US
11.00K employees
CEO: Michael Erickson
Founded: 1991
$584.78
+$0.00(+NaN%)
Market Cap
46.13B
Beta
1.55
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: IDEXX Laboratories trades about 28% above its fair value of $419, with high-confidence DCF suggesting even lower intrinsic worth near $176. Monte Carlo analysis indicates significant downside risk, with all scenarios below current price and high volatility. Strong profitability and efficiency scores contrast with moderate growth and leverage, signaling mixed fundamentals amid valuation concerns.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore IDXX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

IDXX in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Medical - Diagnostics & Research

Browse industry stocks →